Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 500

1.

New options for the therapy of Barrett's high-grade dysplasia and intramucosal adenocarcinoma: endoscopic mucosal resection and ablation versus vagal-sparing esophagectomy.

DeMeester SR.

Ann Thorac Surg. 2008 Feb;85(2):S747-50. doi: 10.1016/j.athoracsur.2007.10.102. Review. No abstract available.

PMID:
18222209
2.

Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma.

Larghi A, Lightdale CJ, Ross AS, Fedi P, Hart J, Rotterdam H, Noffsinger A, Memeo L, Bhagat G, Waxman I.

Endoscopy. 2007 Dec;39(12):1086-91. Epub 2007 Aug 15.

PMID:
17701854
3.

Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.

Chennat J, Konda VJ, Ross AS, de Tejada AH, Noffsinger A, Hart J, Lin S, Ferguson MK, Posner MC, Waxman I.

Am J Gastroenterol. 2009 Nov;104(11):2684-92. doi: 10.1038/ajg.2009.465. Epub 2009 Aug 18.

PMID:
19690526
4.

Treatment of Barrett's esophagus with high-grade dysplasia and intramucosal adenocarcinoma.

Zehetner J, DeMeester SR.

Expert Rev Gastroenterol Hepatol. 2009 Oct;3(5):493-8. doi: 10.1586/egh.09.44. Review.

PMID:
19817671
5.

[Limited surgical resection versus local endoscopic therapy of early cancers of the esophagogastric junction].

von Rahden BH, Feith M, Stein HJ.

Zentralbl Chir. 2006 Apr;131(2):97-104. Review. German.

PMID:
16612774
6.

Endoscopic resection and ablation versus esophagectomy for high-grade dysplasia and intramucosal adenocarcinoma.

Zehetner J, DeMeester SR, Hagen JA, Ayazi S, Augustin F, Lipham JC, DeMeester TR.

J Thorac Cardiovasc Surg. 2011 Jan;141(1):39-47. doi: 10.1016/j.jtcvs.2010.08.058. Epub 2010 Nov 5.

7.
8.

Vagal-sparing esophagectomy: the ideal operation for intramucosal adenocarcinoma and barrett with high-grade dysplasia.

Peyre CG, DeMeester SR, Rizzetto C, Bansal N, Tang AL, Ayazi S, Leers JM, Lipham JC, Hagen JA, DeMeester TR.

Ann Surg. 2007 Oct;246(4):665-71; discussion 671-4.

PMID:
17893503
9.

Surgical therapy for Barrett's esophagus with high-grade dysplasia and early esophageal carcinoma.

Gilbert S, Jobe BA.

Surg Oncol Clin N Am. 2009 Jul;18(3):523-31. doi: 10.1016/j.soc.2009.03.008. Review.

PMID:
19500741
10.

Intramucosal esophageal cancer and high-grade dysplasia: which treatment frame the debate.

Oelschlager BK.

J Gastrointest Surg. 2009 Jul;13(7):1169-71. doi: 10.1007/s11605-009-0864-0. Epub 2009 Mar 26. Review. No abstract available.

PMID:
19322615
11.

Treatment of Barrett's esophagus with high-grade dysplasia.

McAllaster JD, Buckles D, Al-Kasspooles M.

Expert Rev Anticancer Ther. 2009 Mar;9(3):303-16. doi: 10.1586/14737140.9.3.303. Review.

PMID:
19275509
12.

Editorial: Resecting or burning: what should we do with the remaining barrett's epithelium after successful ER of neoplasia?

Pech O, Ell C.

Am J Gastroenterol. 2009 Nov;104(11):2693-4. doi: 10.1038/ajg.2009.470.

PMID:
19888235
13.

Occult adenocarcinoma after esophagectomy for Barrett's high-grade dysplasia.

Donnellan F, Harewood GC, Patchett SE.

Gastrointest Endosc. 2010 Feb;71(2):429. doi: 10.1016/j.gie.2009.05.008. No abstract available.

PMID:
20152322
14.

Histopathology of Barrett's esophagus after ablation and endoscopic mucosal resection therapy.

Odze RD, Lauwers GY.

Endoscopy. 2008 Dec;40(12):1008-15. doi: 10.1055/s-0028-1103416. Epub 2008 Dec 8. Review.

PMID:
19065484
15.
16.

The rationale for esophagectomy as the optimal therapy for Barrett's esophagus with high-grade dysplasia.

Edwards MJ, Gable DR, Lentsch AB, Richardson JD.

Ann Surg. 1996 May;223(5):585-9; discussion 589-91.

17.

Endotherapy for Barrett's esophagus with high-grade dysplasia and intramucosal carcinoma.

Schembre DB.

J Gastrointest Surg. 2009 Jul;13(7):1172-8. doi: 10.1007/s11605-009-0862-2. Epub 2009 Mar 26. Review. No abstract available.

PMID:
19322616
18.

High-grade dysplasia and intramucosal adenocarcinoma in Barrett's esophagus: the role of esophagectomy in the era of endoscopic eradication therapy.

Luna RA, Gilbert E, Hunter JG.

Curr Opin Gastroenterol. 2012 Jul;28(4):362-9. doi: 10.1097/MOG.0b013e328353e346. Review.

PMID:
22517568
19.

Endoscopic versus surgical therapy for early cancer in Barrett's esophagus: a decision analysis.

Pohl H, Sonnenberg A, Strobel S, Eckardt A, Rösch T.

Gastrointest Endosc. 2009 Oct;70(4):623-31. doi: 10.1016/j.gie.2008.11.047. Epub 2009 Apr 25.

PMID:
19394011
20.

Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.

Chennat J, Ross AS, Konda VJ, Lin S, Noffsinger A, Hart J, Waxman I.

Gastrointest Endosc. 2009 Sep;70(3):417-21. doi: 10.1016/j.gie.2009.01.047. Epub 2009 Jun 24.

PMID:
19555948

Supplemental Content

Support Center